- Home
- PFD vs LUCD Comparison
PFD vs LUCD Comparison
Compare PFD & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFD
- LUCD
- Stock Information
- Founded
- PFD 1990
- LUCD 2018
- Country
- PFD United States
- LUCD United States
- Employees
- PFD N/A
- LUCD N/A
- Industry
- PFD Investment Managers
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PFD Finance
- LUCD Health Care
- Exchange
- PFD Nasdaq
- LUCD Nasdaq
- Market Cap
- PFD 144.5M
- LUCD 135.6M
- IPO Year
- PFD N/A
- LUCD 2021
- Fundamental
- Price
- PFD $11.08
- LUCD $1.13
- Analyst Decision
- PFD
- LUCD Strong Buy
- Analyst Count
- PFD 0
- LUCD 4
- Target Price
- PFD N/A
- LUCD $3.88
- AVG Volume (30 Days)
- PFD 33.2K
- LUCD 961.7K
- Earning Date
- PFD 01-01-0001
- LUCD 05-14-2025
- Dividend Yield
- PFD 6.30%
- LUCD N/A
- EPS Growth
- PFD N/A
- LUCD N/A
- EPS
- PFD N/A
- LUCD N/A
- Revenue
- PFD N/A
- LUCD $4,346,000.00
- Revenue This Year
- PFD N/A
- LUCD $107.75
- Revenue Next Year
- PFD N/A
- LUCD $231.37
- P/E Ratio
- PFD N/A
- LUCD N/A
- Revenue Growth
- PFD N/A
- LUCD 79.00
- 52 Week Low
- PFD $8.53
- LUCD $0.63
- 52 Week High
- PFD $11.18
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- PFD 58.60
- LUCD 36.90
- Support Level
- PFD $10.95
- LUCD $1.19
- Resistance Level
- PFD $11.10
- LUCD $1.24
- Average True Range (ATR)
- PFD 0.10
- LUCD 0.07
- MACD
- PFD 0.04
- LUCD -0.01
- Stochastic Oscillator
- PFD 88.54
- LUCD 4.17
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.